XML 57 R40.htm IDEA: XBRL DOCUMENT v3.25.0.1
Fair Value Measurements - Narrative (Details)
$ in Thousands
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent royalty obligation payable to Evolus Founders $ 44,765 $ 45,030 $ 46,310 $ 44,740
Fair Value | Pharmakon Term Loans        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent royalty obligation payable to Evolus Founders $ 132,078 $ 140,241    
Contingent Royalty Obligation | Measurement Input, Discount Rate | Maximum        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Measurement input 0.14 0.15